Israel Chemicals (NYSE:ICL) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.29 by 3.45 percent. This is a 7.69 percent increase over earnings of $0.26 per share from the
Psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem.
Companies partnering to develop CO2-derived protein ingredients for food applications, using Arkeon's carbon conversion process
ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today